AIM ImmunoTech (AIM) Revenue Growth (3y) (2013 - 2026)
AIM ImmunoTech (AIM) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 10.17% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.76% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 77.85% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -25.02% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 42.02% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 59.40% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -37.68% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 76.62% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 7.80% |
| 10 | AIM ImmunoTech | 4.43 Mn | -5.53 Mn | 21,000.00 | -14.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -14.77% |
| Mar 31, 2026 | -23.43% |
| Dec 31, 2025 | -27.89% |
| Sep 30, 2025 | 7.38% |
| Jun 30, 2025 | -5.90% |
| Mar 31, 2025 | -21.44% |
| Dec 31, 2024 | -3.45% |
| Sep 30, 2024 | 1.98% |
| Jun 30, 2024 | 29.54% |
| Mar 31, 2024 | 12.62% |
| Dec 31, 2023 | 15.67% |
| Sep 30, 2023 | 8.51% |
| Jun 30, 2023 | 1.64% |
| Mar 31, 2023 | 2.88% |
| Dec 31, 2022 | 3.85% |
| Sep 30, 2022 | -29.91% |
| Jun 30, 2022 | 1.14% |
| Dec 31, 2021 | -40.72% |
| Sep 30, 2021 | -4.59% |
| Jun 30, 2021 | -11.34% |